OTCMKTS:BVNRY Bavarian Nordic A/S (BVNRY) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free BVNRY Stock Alerts $7.73 +0.06 (+0.78%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$7.73▼$7.7750-Day Range$6.92▼$8.4052-Week Range$5.95▼$10.65Volume1,402 shsAverage Volume1,596 shsMarket Capitalization$1.81 billionP/E Ratio12.26Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Bavarian Nordic A/S alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Bavarian Nordic A/S Stock (OTCMKTS:BVNRY)Bavarian Nordic A/S is a fully-integrated biotechnology company focused on vaccination technology. The company’s work is built around two primary platforms that provide numerous benefits to the health industry and individuals. The company’s primary technology is MVA-BN which stands for Modified Vaccine Ankara-Bavarian Nordic. This vaccination platform is a non-replicating platform, meaning that live-virus vaccines cannot reproduce and spread within the host. This is central to the platform's high tolerance rate. MVA-BN is approved as a smallpox and monkeypox vaccine in the US, Canada, and the EU. It is also included in the US Strategic National Stockpile and is being used worldwide to control the 2022 Monkeypox outbreak.Bavarian Nordic is headquartered in Hellerup, Denmark with manufacturing sites in Denmark and Germany. The company maintains offices in Switzerland, the UK, Japan, and North Carolina in the United States. The company was incorporated in 1992 and had 4 approved products under 7 brand names available for use. Its MVA-BN non-replicating smallpox and monkeypox vaccines are available under the IMVAMUNE, IMVANEX and JYNNEOS names.The company’s second platform is the Vaccinia-Fowlpox-TRICOM platform for treating cancers. The platform can be targeted to attack specific markers found in numerous cancers. The company’s other marketable vaccines are Rabipur for rabies, MVABEA for Ebola and Marburg Hemorrhagic fever, and Encepur for tick-borne encephalitis.The company’s pipeline has 4 potential candidates for the market. These include a freeze-dried version of MVA-BN for smallpox, MVA-BN for RSV (respiratory infection), and TAEK-VAC for certain cancers. The company’s COVID-19/SARS vaccine boosters have shown effectiveness 6 months after dosing. Written by Jeffrey Neal JohnsonRead More BVNRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BVNRY Stock News HeadlinesMay 8, 2024 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic Announces Interim Results for the First Three Months of 2024May 8, 2024 | finance.yahoo.comBavarian Nordic Announces Interim Results for the First Three Months of 2024May 12, 2024 | Stansberry Research (Ad)Gold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).May 8, 2024 | finance.yahoo.comBavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme ObligationsMay 5, 2024 | finance.yahoo.comBavarian Nordic A/S (BV3A.SG)May 4, 2024 | americanbankingnews.comBavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Passes Below 200-Day Moving Average of $7.61May 2, 2024 | msn.comBavarian Podcast Works: Weekend Warm-up Show Season 3, Episode 43 — Ralf Rangnick rejected Bayern Munich...now what?; Jonathan Tah to Bayern?; What to expect from round two ...May 1, 2024 | msn.comBavarian Podcast Works — Preview Show: VfB Stuttgart vs. Bayern Munich (Bundesliga)May 12, 2024 | Stansberry Research (Ad)Gold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).April 30, 2024 | msn.comBavarian Podcast Works — Preview Show: Bayern Munich vs. Real Madrid (Champions League)April 29, 2024 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic ReserveApril 29, 2024 | msn.comBavarian Podcast Works S6E42: Is Bayern Munich becoming too toxic to coach? How Hoeneß’s row with Tuchel might affect the Real Madrid gameApril 29, 2024 | globenewswire.comBavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic ReserveApril 29, 2024 | finance.yahoo.comBavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine CandidateApril 29, 2024 | finanznachrichten.deBavarian Nordic A/S: Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine CandidateApril 27, 2024 | finance.yahoo.comBavarian Nordic A/S (BVNRY)April 22, 2024 | seekingalpha.comBVNKF Bavarian Nordic A/SApril 16, 2024 | finance.yahoo.comResolutions of the Annual General Meeting 2024 of Bavarian Nordic A/SApril 13, 2024 | msn.comWeekend Warm-up: With Serge Gnabry’s future at Bayern Munich uncertain, Chris Führich and Bayern Munich could be getting close; Bundesliga predictions; Throwing it back to ...April 3, 2024 | msn.comBavarian Nordic launches mpox vaccine in United StatesApril 3, 2024 | msn.comBavarian Nordic expands access to mpox vaccine in USApril 2, 2024 | finance.yahoo.comBavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.March 30, 2024 | msn.comNorwegians facing a shortage as Easter nears are hoarding eggs from neighboring SwedenMarch 16, 2024 | msn.comFrankenmuth kicks off the start of Osterbrunnen: Bavarian EasterMarch 14, 2024 | wsj.comNordic Economic Growth to Pick Up This Year, But With DivergenceMarch 14, 2024 | wsj.comNordic Capital Bets on Digital Payments Backing InsurTech One IncMarch 13, 2024 | finance.yahoo.comBavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in SwitzerlandSee More Headlines Receive BVNRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today5/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:BVNRY CUSIPN/A CIKN/A Webwww.bavarian-nordic.com Phone(453) 326-8383Fax45-3326-8380Employees1,379Year Founded1994Profitability EPS (Most Recent Fiscal Year)$0.63 Trailing P/E Ratio12.26 Forward P/E Ratio14.86 P/E GrowthN/ANet Income$214.09 million Net Margins14.74% Pretax Margin12.92% Return on Equity16.11% Return on Assets10.79% Debt Debt-to-Equity RatioN/A Current Ratio1.55 Quick Ratio0.94 Sales & Book Value Annual Sales$1.02 billion Price / Sales1.77 Cash Flow$0.03 per share Price / Cash Flow223.37 Book Value$4.77 per share Price / Book1.62Miscellaneous Outstanding Shares234,290,000Free FloatN/AMarket Cap$1.81 billion OptionableNot Optionable Beta1.50 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Paul John Chaplin MSc (Age 57)Ph.D., CEO & President Comp: $2.09MMr. Henrik Juuel M.Sc. (Age 59)CFO & Executive VP Comp: $1.16MMr. Russell Thirsk M.Sc. (Age 56)Executive VP & COO Mr. Rolf Sass SørensenVice President of Investor Relations & CommunicationsMs. Anu Helena Kerns M.Sc. (Age 52)Executive VP and Chief People & Sustainability Officer Mr. Jean-Christophe May M.B.A. (Age 57)Pharm.D., Executive VP & Chief Commercial Officer Dr. Laurence De Moerlooze Ph.D. (Age 60)Executive VP & Chief Medical Officer More ExecutivesKey CompetitorsFusion PharmaceuticalsNASDAQ:FUSNInhibrxNASDAQ:INBXBeam TherapeuticsNASDAQ:BEAMGinkgo BioworksNYSE:DNAADMA BiologicsNASDAQ:ADMAView All Competitors BVNRY Stock Analysis - Frequently Asked Questions How have BVNRY shares performed in 2024? Bavarian Nordic A/S's stock was trading at $8.7450 at the beginning of the year. Since then, BVNRY stock has decreased by 11.7% and is now trading at $7.7250. View the best growth stocks for 2024 here. Are investors shorting Bavarian Nordic A/S? Bavarian Nordic A/S saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 100 shares, a decrease of 87.5% from the April 15th total of 800 shares. Based on an average daily trading volume, of 3,100 shares, the short-interest ratio is presently 0.0 days. View Bavarian Nordic A/S's Short Interest. How were Bavarian Nordic A/S's earnings last quarter? Bavarian Nordic A/S (OTCMKTS:BVNRY) announced its quarterly earnings data on Wednesday, March, 6th. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.44 by $0.12. The firm earned $353.27 million during the quarter, compared to analyst estimates of $340.71 million. Bavarian Nordic A/S had a trailing twelve-month return on equity of 16.11% and a net margin of 14.74%. How do I buy shares of Bavarian Nordic A/S? Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BVNRY) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchYou need to know these two things about AI stocks ASAP…InvestorPlace[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bavarian Nordic A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
